Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension

Clinical trial NCT01637675 · UNKNOWN

Trial details

NCT number: NCT01637675
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Pulmonary Arterial Hypertension Cardiovascular Diseases Lung Diseases Tanshinone IIA Sulfonate

Start date: 2013-05-01
Primary completion: 2014-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.